Barbara Eicher

Barbara Eicher is a Scientist specializing in Antibody Development at Memo Therapeutics AG since October 2018, following a role as an Associate II in Protein Engineering at Numab Innovation AG from January 2017 to September 2018. With a robust background in protein engineering and characterization, Barbara has held various positions at ESBATech, a Novartis company, including Scientist II and I in Protein Engineering, and has contributed to the development and analysis of antibody fragments. This experience includes detailed characterization of lead candidates, execution of stability studies, and method development. Barbara's academic foundation includes a Master of Science in Biology from the University of Zurich, obtained in 2009.